SUMMARY
Copy number variations (CNVs) have been involved in multiple genomic disorders but their impact on complex traits remains understudied. We called CNVs in the UK Biobank and performed genome-wide association scans (GWASs) between the copy-number of CNV-proxy probes and 57 continuous traits, revealing 131 signals spanning 47 phenotypes. Our analysis recapitulated well-known associations (1q21 and height), revealed the pleiotropy of recurrent CNVs (26 traits for 16p11.2-BP4-BP5), and suggested new gene functionalities (MARF1 in female reproduction). Forty CNV signals overlapped known GWAS loci (RHD deletion and hematological traits). Conversely, others overlapped Mendelian disorder regions, suggesting variable expressivity and a broad impact of these loci, as illustrated by signals mapping to Rotor syndrome (SLCO1B1/3), renal cysts and diabetes (HNF1B), or Charcot-Marie-Tooth (PMP22) loci. The total CNV burden negatively impacted 35 traits, leading to increased adiposity, liver/kidney damage, and decreased intelligence and physical capacity. Thirty traits remained burden-associated after correcting for CNV-GWAS signals, pointing to a polygenic CNV-architecture. The burden negatively correlated with socio-economic indicators, parental lifespan, and age (survivorship proxy), suggesting that CNVs contribute to decreased longevity. Together, our results showcase how studying CNVs can reveal new biological insights, emphasizing the critical role of this mutational class in shaping complex traits.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by funding from the Department of Computational Biology (Z.K.) and the Center for Integrative Genomics (A.R.) from the University of Lausanne, as well as grants from the Swiss National Science Foundation (31003A_182632 to A.R.), Horizon2020 Twinning projects (ePerMed 692145 to A.R.), and the Estonian Research Council (PRG687, M.L. and R.M.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
UK Biobank: Participants signed a broad informed consent form and data was accessed through the application number 16389. Estonian Biobank: Participants signed a broad informed consent form and analyses were carried out under ethical approval 1.1-12/624 from the Estonian Committee on Bioethics and Human Research and data release N05 from the EstBB. CHUV maternity cohort: Approval from the Ethics Committee of Vaud (CER-VD) was obtained for data reusage under the project ID 2019-00280 to investigate maternal and fetal outcomes.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
LIST OF ABBREVIATIONS
- ALT
- alanine aminotransferase
- BAF
- B allele frequency
- BMI
- body mass index
- CMT
- Charcot-Marie Tooth
- CN
- copy number
- CNV
- copy-number variant
- CNVR
- CNV region
- CRP
- C-reactive protein
- EA
- educational attainment
- EstBB
- Estonian Biobank
- eQTL
- expression quantitative locus
- GGT
- γ-glutamyl transferase
- GW
- genome-wide
- GWAS
- genome-wide association study
- HbA1c
- glycated hemoglobin
- IBS0
- identity by state at 0
- ICD-10
- International Classification of Diseases, 10th Revision
- LCR
- low copy repeat
- LDL
- low-density lipoprotein
- LRR
- Log R ratio
- MODY
- maturity-onset diabetes of the young
- TWMR
- transcriptome-wide Mendelian randomization
- PFB
- population frequency of B allele
- QC
- quality control
- QS
- quality score
- RCAD
- renal cysts and diabetes
- Rh
- Rhesus
- SCr
- serum creatinine
- SNP
- single nucleotide polymorphism
- UKBB
- UK Biobank
- WB
- whole blood
- WHR
- waist-to-hip ratio
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.